| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/04/2010 | US20100055120 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 03/04/2010 | US20100055119 Peptides sequences and compositions |
| 03/04/2010 | US20100055115 Compositions and methods for stem cell delivery |
| 03/04/2010 | US20100055114 Use of integrin alpha 10 binding antibody to modulate extracellular matrix (cartilage) turnover |
| 03/04/2010 | US20100055109 Post-translationally modified neurotrophins |
| 03/04/2010 | US20100055106 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/04/2010 | US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof |
| 03/04/2010 | US20100055101 Cytokine receptor zcytor17 multimers |
| 03/04/2010 | US20100055093 Pan-cell surface receptor-specific therapeutics |
| 03/04/2010 | US20100055091 Novel GL-50 Molecules and Uses Therefor |
| 03/04/2010 | US20100055085 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 03/04/2010 | US20100055070 Cytokine-based fusion proteins for treatment of immune disorders |
| 03/04/2010 | US20100055069 Hpv-18-based papillomavirus vaccines |
| 03/04/2010 | CA2740487A1 Resistance genes |
| 03/04/2010 | CA2737761A1 Vaccine compositions |
| 03/04/2010 | CA2735522A1 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc |
| 03/04/2010 | CA2735502A1 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer |
| 03/04/2010 | CA2735456A1 Method and compositions for enhanced anti-tumor effector functioning of t cells |
| 03/04/2010 | CA2735278A1 Hiv-1 envelope polypeptides for hiv vaccine |
| 03/04/2010 | CA2735214A1 Radiolabeled annexins |
| 03/04/2010 | CA2735171A1 Prevention, treatment and diagnosis of p.gingivalis infection |
| 03/04/2010 | CA2734174A1 Anln protein as an endocrine treatment predictive factor |
| 03/04/2010 | CA2733283A1 Clostridial neurotoxins with altered persistency |
| 03/04/2010 | CA2732215A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies |
| 03/03/2010 | EP2159281A1 Novel slc17-type transporter protein in mammal and use thereof |
| 03/03/2010 | EP2158917A1 P.ariasi polypeptides, P.perniciosus polypeptides and methods of use |
| 03/03/2010 | EP2158488A2 Mutated parvovirus structural proteins as vaccines |
| 03/03/2010 | EP2158487A1 Parkin substrate and assay |
| 03/03/2010 | EP2158216A1 Splice-variants of g-protein coupled receptor ep3 and uses thereof |
| 03/03/2010 | EP2158215A2 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 03/03/2010 | EP2158214A1 Glucagon analogues |
| 03/03/2010 | EP2158213A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats |
| 03/03/2010 | EP2158212A2 Rhd6 and its use in modulating plant root hair development |
| 03/03/2010 | EP2158211A2 Mutated structural protein of a parvovirus |
| 03/03/2010 | EP2158210A2 Rage fusion proteins |
| 03/03/2010 | EP2157979A1 Calcium channel proteins and uses thereof |
| 03/03/2010 | EP2157967A2 Suspension formulations of insulinotropic peptides and uses thereof |
| 03/03/2010 | EP1891102B1 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12 |
| 03/03/2010 | EP1828225B1 Purified rhigf-i/rhigfbp-3 complexes and their method of manufacture |
| 03/03/2010 | EP1756270B1 Diagnosis and treatment of myeloid and lymphoid cell cancers with chlorotoxin or a derivative |
| 03/03/2010 | EP1743648B1 Method for treating inflammation |
| 03/03/2010 | EP1694848B1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 03/03/2010 | EP1613274B1 Human il-18 substitution mutants and their conjugates |
| 03/03/2010 | EP1569683B1 Modified natriuretic compounds, conjugates, and uses thereof |
| 03/03/2010 | EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics |
| 03/03/2010 | EP1490482B1 Host cells having improved cell survival properties and methods to generate such cells |
| 03/03/2010 | EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury |
| 03/03/2010 | EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 03/03/2010 | EP0990030B1 Transcriptional activators with graded transactivation potential |
| 03/03/2010 | EP0973381B1 Animal model for evaluation of vaccines |
| 03/03/2010 | EP0859831B1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 03/03/2010 | CN101663317A glucagon-like protein-1 receptor (glp-1r) agonist compounds |
| 03/03/2010 | CN101663316A Mannoprotein liquid formulations |
| 03/03/2010 | CN101663315A Peptide vaccines for cancers expressing tumor-associated antigens |
| 03/03/2010 | CN101659704A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 03/03/2010 | CN101659701A Human growth hormone crystals and methods for preparing them |
| 03/03/2010 | CN101659700A Short peptide |
| 03/03/2010 | CN101659699A Plant stress resistance-related protein GmSIK2 and coding gene and application thereof |
| 03/03/2010 | CN101659698A Violacein synthesized related protein system, coding gene cluster thereof and application thereof |
| 03/03/2010 | CN101659697A Cracking method of human respiratory syncytial virus |
| 03/03/2010 | CN101659696A Asia I-type aftosa synthetic peptide vaccine |
| 03/03/2010 | CN101659695A O-type aftosa synthetic peptide vaccine |
| 03/03/2010 | CN101658669A Attenuated live vaccine |
| 03/03/2010 | CN100593037C Bacillus thuringiensis toxins and genes for controlling coleopteran pests |
| 03/03/2010 | CN100593034C Alpha-amylase mutants |
| 03/02/2010 | USRE41157 Microparticle carriers of maximal uptake capacity by both M cells and non-M cells |
| 03/02/2010 | US7671258 Surfactant peptide nanostructures, and uses thereof |
| 03/02/2010 | US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV) |
| 03/02/2010 | US7671185 Polynucleotide encoding a variant polypeptide of wild-type DsRed or DsRed.T4, a tetrameric variant that has reduced oligomerization relative wild-type DsRed and a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed |
| 03/02/2010 | US7671183 PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use |
| 03/02/2010 | US7671182 Gene variants of signal transducer and activator of transcription-6 (STAT 6) variants and process of detection the same |
| 03/02/2010 | US7671181 Protozoan serine/threonine kinase for identifying modulators for use in targeted destruction tumor cells; veterinary medicine |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671178 Silk is dissolved in an ionic liquid (1-butyl-3-methylimidazolium chloride) and is regenerated in a range of structural forms without requiring the use of harmful solvents; solubility |
| 03/02/2010 | US7671177 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 03/02/2010 | US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists |
| 03/02/2010 | US7671174 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR) |
| 03/02/2010 | US7671036 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/02/2010 | US7671024 Antilipemic agents; anticholesterol agents; antidiabetic agents; hypotensive agents; administering polypeptide; useful for treating obesity-related diseases and disorders |
| 03/02/2010 | US7671022 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens |
| 03/02/2010 | US7671021 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 03/02/2010 | US7671020 Methods of increasing cartilage deposition using FGF homologs |
| 03/02/2010 | US7671018 Applying at the repair site a therapeutically effective amount of a proteoglycan that comprises the amino acid sequence of the core protein of domain I of a mammalian perlecan to which at least one glycosaminoglycan is attached |
| 03/02/2010 | US7671016 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 03/02/2010 | US7671015 treating an ischemic insult to neurons in a subject's brain by administering to the brain of a subject in need of such treatment an effective amount of aequorin |
| 03/02/2010 | US7671009 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin |
| 03/02/2010 | US7670855 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| 03/02/2010 | US7670852 very early marker of fertilization and embryo viability; binds to anti-CD2 antibody; Infertility |
| 03/02/2010 | US7670851 Assays for preimplantation factor and preimplantation factor peptides |
| 03/02/2010 | US7670850 Assays for preimplantation factor and preimplantation factor peptides |
| 03/02/2010 | US7670839 Process for coating cell-culture support |
| 03/02/2010 | US7670836 Antimicrobial peptide isolated from Penaeus monodon |
| 03/02/2010 | US7670835 diagnosis of and vaccination against Streptococcal infections ; detection of virulence markers of Streptococci |
| 03/02/2010 | US7670828 Expression vector comprising nucleotide sequences coding genes associated with alcohol fermentation; for generating transgenic saccharomyces; improving productivity and/or flavor of alcoholic beverages |
| 03/02/2010 | US7670826 Belonging to subfamily of human immunoglobulin superfamily; isolated antibodies and nucleic acids; transformed host cells; modulating transendothelial migration of leukocytes; inflammation, tumors |
| 03/02/2010 | US7670817 Dynamin mediated diseases and associated methods and products |
| 03/02/2010 | US7670805 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 03/02/2010 | US7670802 CXC-chemokine antagonists isolated from Rhipicephalus sanguineus |
| 03/02/2010 | US7670787 Protein forming complex with c-Fos protein, nucleic acid encoding the same and method of using the same |
| 03/02/2010 | US7670778 Using malignant brain tumor (MBT) repeat protein (LIN-61) as tool in identifying modulators for prevention and treatment of cell proliferative disorders |